Correlation Between GlaxoSmithKline PLC and Locorr Spectrum

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Locorr Spectrum at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Locorr Spectrum into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Locorr Spectrum Income, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Locorr Spectrum and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Locorr Spectrum. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Locorr Spectrum.

Diversification Opportunities for GlaxoSmithKline PLC and Locorr Spectrum

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between GlaxoSmithKline and Locorr is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Locorr Spectrum Income in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Locorr Spectrum Income and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Locorr Spectrum. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Locorr Spectrum Income has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Locorr Spectrum go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Locorr Spectrum

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Locorr Spectrum. In addition to that, GlaxoSmithKline PLC is 2.75 times more volatile than Locorr Spectrum Income. It trades about -0.05 of its total potential returns per unit of risk. Locorr Spectrum Income is currently generating about 0.07 per unit of volatility. If you would invest  513.00  in Locorr Spectrum Income on September 18, 2024 and sell it today you would earn a total of  32.00  from holding Locorr Spectrum Income or generate 6.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.4%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Locorr Spectrum Income

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Locorr Spectrum Income 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Locorr Spectrum Income has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Locorr Spectrum is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Locorr Spectrum Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Locorr Spectrum

The main advantage of trading using opposite GlaxoSmithKline PLC and Locorr Spectrum positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Locorr Spectrum can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Locorr Spectrum will offset losses from the drop in Locorr Spectrum's long position.
The idea behind GlaxoSmithKline PLC ADR and Locorr Spectrum Income pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
CEOs Directory
Screen CEOs from public companies around the world